在接受本拉利祖马布或梅波利祖马布治疗的多胞膜炎的异性粒状炎患者中,停止口服葡萄糖皮质类药物治疗并实现缓解
Michael E Wechsler1, Nancy Agmon-Levin2, David R W Jayne3
1National Jewish Health, Denver, Colorado.
ACR open rheumatology
|August 31, 2025
概括
与梅波利祖马布相比,本拉利祖马布在聚炎患者中表现出更高的口服葡萄糖皮质类药物完全缓解率. 这表明添加抗IL-5/ R疗法可能会改善EGPA的治疗反应.
科学领域:
- 免疫学
- 关节病学
- 临床试验
背景情况:
- 带有多炎的乳酸性粒状炎 (EGPA) 是一种罕见的自身免疫性疾病.
- 目前的治疗通常涉及口服葡萄皮质激素 (OGCs),它们具有显著的副作用.
- 实现和维持缓解,特别是没有OGC,是治疗的关键目标.
研究的目的:
- 为了比较本拉利祖马布与梅波利祖马布在EGPA患者中达到缓解的严格定义的疗效.
- 评估患者从OGC中缓解并保持无复发的比例.
主要方法:
- 在MANDARA研究中,140名EGPA患者随机接受本拉利祖马布或梅波利祖马布治疗52周.
- 缓解被定义为BVAS为0,OGC剂量为0毫克/天,在第36周和第48周没有复发.
- 患者在基线接受OGC,可能同时接受免疫抑制疗法.
主要成果:
- 在23. 5%的患者中,本拉利祖马布实现了OGC的缓解,而梅波利祖马布的缓解率为11. 1% (P=0. 042).
- 在接受本拉利祖马布治疗的患者中,更高的百分比实现了这一严格的缓解终点.
- 大多数患者在治疗后36周内得到缓解.
结论:
- 本拉利祖马布和梅波利祖马布可以帮助EGPA患者停止OGC,同时预防复发.
- 在本试验中,本拉利祖马布在实现无OGC缓解方面表现出显著的统计优势.
- 将抗IL-5/ R治疗添加到标准EGPA治疗中可能会改善患者的结果.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
Antiasthma Drugs: Leukotriene Modifiers
461
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
461
Drugs Used in Lower Respiratory Disorders: Overview
575
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
575
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
383
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
383


